Valuation: Stille AB

Market Cap 208.46Cr 22Cr 19Cr 18Cr 16Cr 30Cr 2.11TCr 31Cr 81Cr 1.06TCr 83Cr 81Cr 3.5TCr P/E 2026 *
25.9x
P/E 2027 * 19.4x
Enterprise Value 202.01Cr 21Cr 18Cr 17Cr 16Cr 29Cr 2.04TCr 30Cr 79Cr 1.03TCr 80Cr 78Cr 3.39TCr EV / Sales 2026 *
2.79x
EV / Sales 2027 * 2.44x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.86%
1 day+1.09%
1 week-2.93%
Current month+1.75%
1 month-6.83%
3 months-6.45%
6 months+19.59%
Current year+18.37%
1 week 226
Extreme 226
240.5
1 month 222.5
Extreme 222.5
274
Current year 143
Extreme 143
283
1 year 143
Extreme 143
283
3 years 94.2
Extreme 94.2
283
5 years 94.2
Extreme 94.2
283
10 years 24
Extreme 24
283
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Director/Board Member 62 01/01/2023
Date Insider Type Main position Quantity % Market Cap.
26/02/26 Buy

Director

543 0.0060%
24/02/26 Buy

Director

540 0.0060%
24/02/26 Buy

Director

75 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%-2.93%+3.11%+118.87% 22Cr
+0.64%+2.40%-29.19%-45.45% 1.54TCr
-1.16%+0.75%+29.33%+133.08% 466.45Cr
-0.94%-2.04%+233.96%+204.16% 321.01Cr
-3.04%-0.17%-31.15%-28.73% 251.39Cr
-0.99%+1.60%-49.78%-57.29% 200.61Cr
-3.19%-2.78%-33.36%-27.71% 181.54Cr
0.00%+1.53%+8.13%-19.39% 132.03Cr
+1.50%-5.78%-1.25%-15.16% 103.51Cr
-4.35%-5.03%-7.71%+7.73% 94Cr
Average -1.04%-1.59%+12.21%+27.01% 331.48Cr
Weighted average by Cap. -0.49%+0.17%+6.09%+9.95%

Financials

2026 *2027 *
Net sales 72Cr 7.64Cr 6.54Cr 6.12Cr 5.61Cr 11Cr 730.97Cr 11Cr 28Cr 367.2Cr 29Cr 28Cr 1.21TCr 80Cr 8.41Cr 7.2Cr 6.74Cr 6.17Cr 12Cr 804.35Cr 12Cr 31Cr 404.06Cr 32Cr 31Cr 1.34TCr
Net income 8.06Cr 85.11L 72.9L 68.21L 62.44L 1.17Cr 81Cr 1.19Cr 3.14Cr 41Cr 3.2Cr 3.13Cr 135.3Cr 11Cr 1.13Cr 96.97L 90.73L 83.05L 1.56Cr 108.31Cr 1.58Cr 4.18Cr 54Cr 4.25Cr 4.16Cr 179.96Cr
Net Debt -6.45Cr -68.15L -58.38L -54.63L -50L -93.84L -65Cr -95.08L -2.52Cr -33Cr -2.56Cr -2.5Cr -108.35Cr -15Cr -1.54Cr -1.32Cr -1.24Cr -1.13Cr -2.12Cr -147.51Cr -2.15Cr -5.69Cr -74Cr -5.79Cr -5.66Cr -245.1Cr
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
225
Date Price Change Volume
21/26/21 SEK 232.00 +1.09% 2,615
20/26/20 SEK 229.50 -0.22% 3,156
19/26/19 SEK 230.00 -1.50% 2,989
18/26/18 SEK 233.50 -0.43% 4,955
17/26/17 SEK 234.50 -1.88% 1,751
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
232.00SEK
Average target price
285.75SEK
Spread / Average Target
+23.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STIL Stock